Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells

Clinical and Experimental Immunology

Volumn 116, Issue 2, 1999, Pages 360-365

  Nagashima, Masakazu ^b   Yoshino, S ^c   Aono, H ^a   Takai, M ^a   Sasano, M ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NONE

Author keywords

Angiogenesis; Disease modifying anti rheumatic drugs; Rheumatoid arthritis; Synoviocytes; Vascular endothelial growth factor

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; BUCILLAMINE; LIPOPOLYSACCHARIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0342993407     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00876.x     Document Type: Article

References (45)

1. 1 Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
2. 2 Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N. Vascular endothelial growlh factor is a secreted angiogenic mitogen. Science 1989; 246:1306-9.
3. 3 Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994; 54:276-80.
4. 4 Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD, Smith SK. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993; 99:609-15.
5. 5 Brown LF, Berse B, Tognazzi K. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992; 42:1457-61.
6. 6 Houck KA, Ferrara N, Winer J, Cachianes GI, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5:1806-14.
7. 7 Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53:4727-35.
8. 8 Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R. Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 1993; 194:749-55.
9. 9 Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359:845-8.
10. 10 Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161:851-8.
11. 11 Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91:2235-43.
12. 12 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiatet angiogenesis. Nature 1992; 359:843-5.
13. 13 Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-7.
14. 14 McClure N, Healy DL, Robertoson DM. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344:235-6.
15. 15 Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-5.
16. 16 Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995; 22:1624-30.
17. 17 Jackson JR, Minton JAL, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1 β. J Rheumatol 1997; 24:1253-9.
18. 18 Hashimoto K, Lipsky PE. Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites. J Rheumatol 1993; 20:953-7.
19. 19 Sanders KM, Carlson PL, Littman BH. Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA-DR expression by human monocytes. Arthritis Rheum 1987; 30:1032-9.
20. 20 Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 1951; 221:176-82.
21. 21 Brody M, Bohm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin-1β to the interleukin 1 receptor on target cells. Eur J Clin Chem Clin Biochem 1993; 31:667-74.
22. 22 Seitz M, Dewald B, Ceska M, Gerber S, Baggiolini M. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992; 12:159-64.
23. 23 Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Baggiolini M, Gerber NJ. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1993; 34:602-9.
24. 24 Carlin G, Djursäter R, Smedegǎrd G. Sulfasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds. Ann Rheum Dis 1992; 51:1230-6.
25. 25 Carlin G, Djursäter R, Smedegǎrd G. Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear lymphocytes. Pharmacol Toxicol 1989; 65:121-7.
26. 26 Koch AE, Cho M, Burrows J, Leibovich SJ, Polverini PJ. Inhibition of production of macrophage-derived angiogenic activity by the antirheumatic agents gold sodium thiomalate and auranofin. Biochem Biophys Res Commun 1988; 154:205-12.
27. 27 Kouda M, Yoshino S, Nakamura H, Asano G. Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1β and IL-6 production by IL-1β-stimulated synovial culture cells. J Nippon Med Sci 1996; 63:1-5.
28. 28 Matsubara T, Ziff M. Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest 1987; 79:1440-6.
29. 29 Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low dose methotrexate. Arthritis Rheum 1989; 32:1065-73.
30. 30 Grootveld M, Blake DR, Sahinoglu T. Control of oxidative damage in rheumatoid arthritis by gold(I)-thiomalate drugs. Free Rad Res Commun 1990; 10:199-200.
31. 31 Matsubara T, Saura R, Hirohata K, Ziff M. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest 1989; 83:158-67.
32. 32 Goto M, Sasano M, Yamanaka H, Miyasaka N, Kamatani N, Inoue K, Nishioka K, Miyamoto T. Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 1987; 80:786-96.
33. 33 Aono H, Hasunuma T, Fujisawa K, Nakajima T, Yamamoto K, Mita S, Nishioka K. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine, J Rheumatol 1996; 23:65-70.
34. 34 Sugawara S, Ishigami M, Kageyama T. Phase 1 study of N-(2-mercapto-2-methylpropionyl)-L-cysteine (SA96). (1) Single administration study. Jpn J Clin Pharmacol Ther 1985; 16:143-52.
35. 35 Massarella JW, Waller ES, Crout JE, Yakatan GJ. The pharmacokinetics of intramuscular gold sodium thiomalate in normal volunteers. Biopharmaceutics Drug Disposition 1983; 5:101-7.
36. 36 Uchida E, Kai K, Kobayashi S, Oguchi K, Miyazaki Y, Yasuhara H. A study of pharmacokinetics and safety of salazosulfapyridine enteric coated tablet (PJ-306) in healthy Japanese subjects. Jpn J Clin Pharmacol Ther 1990; 21:377-89.
37. 37 Furst DE. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. J Rheumatol (Suppl) 1985; 12:11-14.
38. 38 Kageyama Y, Koida Y, Miyamoto S, Yoshida TO, Inoue T. Leukotriene B4-induced interleukin-1β in synovial cells from patients with rheumatoid arthritis. Scand J Rheumatol 1994; 23:148-50.
39. 39 Falus A. Lakatos T, Smolen J. Dissimilar biosynthesis of interleukin-6 by different areas of synovial membrane of patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1992; 21:116-9.
40. 40 Mita S, Matsunaga K. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells. Agents Action 1990; 30:363-8.
41. 41 Hirohata S, Lipsky PE. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Clin Immunol Immunopathol 1993; 66:43-51.
42. 42 Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Kdwards NA, Oldfitield EH. Mechanism of dexamethazone suppression of brain tumor-associated vascular permeability in rats. J Clin Invest 1996; 98:1400-8.
43. 43 Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. J Clin Invest 1988; 81:237-44.
44. 44 Kohase M, Henriken-Destefano D, Sehgal PB. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumour necrosis factor, interleukin-1 and epidermal growth factor in human fibroblasts. J Cell Physiol 1987: 132:271-8.
45. 45 Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P, Perruchoud AP. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down-regulated by corticosteroids. Am J Respir Cell Mol Biol 1997; 16:398-406.